Key result
Dr. Paul Janssen was a highly productive scientist and entrepreneur who developed over 80 pharmaceutical compounds, including the fentanyl family, significantly contributing to anesthesiology.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Highlights Janssen's compounds' lasting role in anesthesia practice; extends historical context for future pharmaceutical innovation research.
In Brief Dr. Paul Janssen was the founder of Janssen Pharmaceutica and the developer of over 80 pharmaceutical compounds that proved useful in human, botanical, and veterinary medicine. He and his coworkers synthesized the fentanyl family of drugs, many other potent analgesics, droperidol, etomidate, and numerous other important medicines that were extremely useful in psychiatry, parasitology, gastroenterology, cardiology, virology, and immunology. Anesthesiology and medicine as a whole have benefited a great deal from his resourcefulness, creativity, and entrepreneurial spirit. IMPLICATIONS: Few in the field of anesthesiology appreciate the sheer magnitude of Dr. Janssen’s numerous contributions to various fields in human, botanical, and veterinary medicine. From the invention and development of over 80 pharmaceutical compounds to his monumental merger of Janssen Pharmacuetica with Johnson and Johnson, Dr. Paul Janssen truly embodies what it means to be a productive scientist and an entrepreneur extraordinaire.
No takes yet. Share an insight, caveat, or question.
Stanley et al. (2008) studied this question. Dr. Paul Janssen was a highly productive scientist and entrepreneur who developed over 80 pharmaceutical compounds, including the fentanyl family, significantly contributing to anesthesiology.
Synapse has enriched 10 related papers. Consider them for comparative context: